Adverum Biotechnologies宣布完成Ixo-Vec治疗湿性年龄相关性黄斑变性关键性三期Artemis试验的患者筛选

美股速递
Sep 22

Adverum Biotechnologies, Inc.宣布,已完成针对湿性年龄相关性黄斑变性的Ixo-Vec疗法关键性三期Artemis试验的患者筛选工作。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10